Routine Cancer Screenings Still Below Prepandemic Levels

Preventive cancer screenings have not completely rebounded almost 3 years after the start of the pandemic, new research suggests. Medscape Medical News

Spontaneous Cancer Regression Extremely Rare

There is virtually no chance of complete regression and only a 1% chance of any response for patients with advanced solid tumors who receive placebo in cancer drug trials. Medscape Medical News

Call for Access to SABR for Inoperable Kidney Cancer

Patients who have larger, inoperable kidney cancers and those unable to undergo surgery should be offered compassionate access to stereotactic ablative body radiotherapy (SABR), say experts. MDedge News

High Cost and Demand for Old Cancer Drug Sparks Crisis

As severe shortages of fludarabine drag on and prices soar, transplant centers are struggling to cope. The drug is an essential component of stem-cell transplants for some blood cancers. MDedge News

Alcohol-Cancer Link; Mpox and Women; Hearing Aids and Dementia

The top 3 things you should know to start your day. 3 Things to Know Today